Our Dual Lens Approach

BVGH works to solve major global health problems by finding the common ground between the needs of patients in poor countries and the pragmatic needs of companies.

Image
 
Image
  
  

Genzyme Says Sanofi Needs to Cough Up More Cash

09/01/2010
Genzyme CEO Henri Termeer tells the Wall Street Journal that Sanofi-Aventis will have to offer more than $69 a share to kick off negotiations. Read more
print